Pharmaceutical group · United States
A group of 6 companies with 18 medicines in 2 countries.
6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
18 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANTIZOL1.5GM/1.5ML (1GM/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Fomepizole | United States | Not marketed | 1997 |
| CHLORPROPAMIDE100mg | 250mg · Tablet | Chlorpropamide | United States | Not marketed | 1980 |
| CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE15mg; 0.1mg | 15mg; 0.2mg | 15mg; 0.3mg · Tablet | Chlorthalidone, Clonidine | United States | Not marketed | 1987 |
| DOXY-SLEEP-AID25mg · Tablet | Doxylamine | United States | Not marketed | |
| FENTANYL CITRATE0.2mg base | 0.4mg base | 0.6mg base | 0.8mg base | 1.2mg base | 1.6mg base · Troche/lozenge | Fentanyl | United States | Not marketed | 2009 |
| HYDRO-RIDE5mg anhydrous; 50mg · Tablet | Amiloride, Hydrochlorothiazide | United States | Not marketed | 1986 |
| MEPROBAMATE AND ASPIRIN325mg; 200mg · Tablet | Acetylsalicylic acid, Meprobamate | United States | Not marketed | |
| METHYLDOPA AND CHLOROTHIAZIDE150mg; 250mg | 250mg; 250mg · Tablet | Chlorothiazide, Methyldopa | United States | Not marketed | |
| MILNACIPRAN HYDROCHLORIDE100mg | 12.5mg | 25mg | 50mg · Tablet | Milnacipran | United States | Marketed | 2015 |
| TRICHLORMETHIAZIDE2mg | 4mg · Tablet | Trichlormethiazide | United States | Not marketed | 1977 |
| VARDENAFIL HYDROCHLORIDE10mg · Tablet, orally disintegrating | Vardenafil | United States | Marketed | 2016 |
| CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE12gm/packet; 3.5gm/packet; 10mg/packet · For solution | Citric acid, Magnesium oxide, Picosulfate | United States | tentative | 2016 |
| DANTRIUM CAPSULES100 mg · Capsule | Dantrolene | Canada | Cancelled | 1993 |
| FINGOLIMOD0.5mg | 0.5mg base · Capsule | Fingolimod | United States | tentative | 2017 |
| LATANOPROST0.005% · Solution | Latanoprost | United States | tentative | 2007 |
| SAXAGLIPTIN5MG · Tablet | Saxagliptin | United States | tentative | 2016 |
| SUMATRIPTAN; NAPROXEN SODIUM85mg; 500mg · Tablet | Sumatriptan, Naproxen | United States | tentative | 2011 |
| TRAVOPROST0.004% · Solution | Travoprost | United States | tentative | 2011 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 17 | 11 | 6 | CompaniesAll medicines |
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Report an error or request removalCorrections from the company itself are welcome.
Keep PAR’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.
